Matthew B Coppock

Title: The Innovative Contributions of Matthew B. Coppock

Introduction

Matthew B. Coppock is a notable inventor based in Adelphi, MD (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, his work focuses on developing advanced immunostimulants and capture agents for target proteins.

Latest Patents

Coppock's latest patents include groundbreaking work on SARS-CoV-2 epitope-targeted peptide immunostimulants. These patents disclose compounds, compositions, and methods related to epitope-targeted immunostimulants (EPIs). The EPIs consist of a synthetic peptide ligand that binds to an epitope on a target, along with an antibody-recruiting moiety that facilitates the recruitment of antibodies to the target. Additionally, the patents describe methods for stimulating immune reactions in subjects and identifying peptide ligands through multi-omic analysis. Another significant patent involves developing virus protein-specific capture agents using cyclic peptide sequences that bind to target proteins, which can be utilized in diagnostics and therapeutics.

Career Highlights

Coppock has worked with esteemed organizations, including the U.S. Government as represented by the Secretary of the Army and the Institute for Systems Biology. His experience in these institutions has allowed him to contribute to important research and development projects in the field of immunology.

Collaborations

Throughout his career, Coppock has collaborated with notable individuals such as James R. Heath and Matthew N. Idso. These collaborations have further enhanced his research and innovation efforts.

Conclusion

Matthew B. Coppock's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in immunostimulants and capture agents, showcasing the importance of innovation in addressing health challenges.